Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 15.14
+0.64 (4.41%)
Jun 12, 2026, 5:29 PM CET
Hemas Holdings Market Cap
Xspray Pharma AB has a market cap or net worth of 717.89 million as of June 12, 2026. Its market cap has decreased by -38.44% in one year.
Market Cap
717.89M
Enterprise Value
745.02M
Revenue
2.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.14
Market Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 717.89M, an increase of 91.07%. That is a compound annual growth rate of 7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 717.89M | -45.32% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 930.82M |
| Infant Bacterial Therapeutics AB | 821.76M |
| SynAct Pharma AB | 771.60M |
| FluoGuide | 721.00M |
| Oncopeptides AB | 699.66M |
| Cantargia AB | 537.00M |
| AlzeCure Pharma AB | 491.83M |